Results 171 to 180 of about 48,298 (265)

How to indicate implantable cardioverter-defibrillator in the aging population. [PDF]

J Arrhythm
Orita R, Kataoka N, Imamura T.
europepmc   +1 more source

When leads are not an option: Optimizing subcutaneous implantable cardioverter-defibrillator and leadless pacemaker interaction. [PDF]

HeartRhythm Case Rep
Muñoz LC, Sánchez-Somonte P, Castrejon-Castrejon S, Martínez-Cossiani M, Al Razzo O, Merino JL.   +5 more
europepmc   +1 more source

Implantable Cardioverter-Defibrillator Therapies Following Generator Replacements-Long-Term Remote Monitoring Data. [PDF]

Clin Pract
Dyrbuś M, Pyka Ł, Kurek A, Niedziela J, Adamowicz-Czoch E, Sokoła K, Machowicz J, Ostręga M, Pres D, Skrzypek M, Gąsior M, Tajstra M.   +11 more
europepmc   +1 more source

Concomitant use of the novel extravascular implantable cardioverter-defibrillator with an epicardial pacemaker. [PDF]

HeartRhythm Case Rep
Graup V, Hofer D, Breitenstein A.
europepmc   +1 more source

Impact of Statement-Concordant Implantable Cardioverter-Defibrillator Programming on Therapy Reduction in an Asian Cohort. [PDF]

JACC Asia
Koya J, Temma T, Kawakami K, Kawasaki M, Shimano K, Saito S, Tatsuta D, Nishino K, Kadosaka T, Koya T, Nakao M, Watanabe M, Kamiya K, Nagai T, Anzai T.   +14 more
europepmc   +1 more source

Ablação de taquicardia ventricular em doentes isquémicos portadores de cardioversor-desfibrilhador implantável [PDF]

, 2015
Vânia Andreia Vasques Constâncio
core  

The St. Jude Medical Riata defibrillator lead advisory:Experience from a Danish nationwide cohort [PDF]

, 2015
Moesgaard, Jacob
core   +2 more sources

Evolution of implantable cardioverter-defibrillator shock therapy in children in the era of optimized ICD programming and remote monitoring. [PDF]

Europace
Bertels RA, Boersma E, Zeggelaar MD, van Dongen SAF, Ten Harkel ADJ, van Erven L, Smeding C, Bartelds B, van den Berg G, Boesaard EP, Bhagwandien RE, Yap SC, Knops RE, Blom NA, Kammeraad JAE.   +14 more
europepmc   +1 more source

Prognostic comparison between implantable cardioverter-defibrillator and amiodarone in cancer patients. [PDF]

J Arrhythm
Kida H, Morishima T, Uza E, Yamamoto H, Yasui T, Fujita M, Miyashiro I.   +6 more
europepmc   +1 more source

Long-Term Implantable Cardioverter Defibrillator Lead Dysfunction After Left Ventricular Assist Device Implantation. [PDF]

JACC Adv
Oshima T, Ishibashi K, Yamagata K, Ueda N, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Nakajima K, Shimizu Y, Watanabe T, Kamakura T, Wada M, Ishida J, Inoue Y, Miyamoto K, Amiya E, Fujiu K, Hatano M, Tsukamoto Y, Aiba T, Fukushima S, Takeda N, Ono M, Kusano K.   +24 more
europepmc   +1 more source